Child Mind Intitute
JULY 14, 2025
When people hear “bipolar disorder,” they think dramatic mood swings or someone suddenly spiraling into mania. That’s the promise of understanding of what is called the bipolar prodrome — the early warning phase that shows up in many kids and teens long before a formal diagnosis is made. “The That’s huge.”
Psychiatric Times
JULY 14, 2025
Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder. Non-pharmacological approaches and combination therapies are emphasized in treatment, with recent FDA approvals for new medications targeting bipolar symptoms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Psychiatric Times
JUNE 25, 2025
News Media Peer Exchange Case-Based Psych Perspectives Clinical Case Collective Insights Peers & Perspectives Slideshows Videos Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Between the Lines Expert Perspectives Clinical Consult Clinical Scales Interactive Tools Partner (..)
Psychiatric Times
AUGUST 1, 2025
Example topics include ADHD's link with bipolar disorder, anxiety, depression, and cardiovascular risks from long-term medication. children, highlighting its significant prevalence and rising diagnosis rates. children, highlighting its significant prevalence and rising diagnosis rates.
Psychiatric Times
JULY 11, 2025
Leah Kuntz October 7th 2021 Blue Light Blockers: A Behavior Therapy for Mania Chris Aiken, MD Kellie Newsome, PMH-NP July 7th 2025 Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? Leah Kuntz October 7th 2021 Blue Light Blockers: A Behavior Therapy for Mania Chris Aiken, MD Kellie Newsome, PMH-NP July 7th 2025 Transformation 2.0:
Psychiatric Times
JULY 7, 2025
Trontinemab showed significant amyloid plaque reduction in Alzheimer's, validating Brainshuttle technology and prompting a phase 3 study. MindMed initiated a phase 3 study of MM120 for major depressive disorder, with results expected in the second half of 2026. Results are expected in 2026.
Psychiatric Times
AUGUST 6, 2025
Many individuals face stress & anxiety from pressure to keep pace in our world today, full of rapid technological changes.This fear may come with the need to get ahead of these changes and attempt to stay more up to date than one’s peers. Innovation anxiety can also stem from a lack of familiarity with a new technology.
Expert insights. Personalized for you.
Let's personalize your content